NCT03980535

New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality

Evaluation of New Magnetic Resonance (MR) Imaging and Spectroscopy Software

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 273 (actual)
• Sponsor: M.D. Anderson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This trial studies how well new magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) software works in improving the image quality of scans in both patients and healthy volunteers. Improving the image quality of MRI and MRSI through new software may lead to implementation of these techniques and better clinical care for patients.

Detailed description

PRIMARY OBJECTIVE: I. To help develop and/or optimize new magnetic resonance (MR) imaging and spectroscopy applications and analysis software in order to provide the best MR services for our patients. OUTLINE: Patients undergo an additional investigational MRI or MRSI sequence along with the standard MRI or MRSI. Healthy volunteers undergo an investigational MRI or MRSI sequence. Healthy volunteers may also undergo an additional standard sequence if there is one that can be compared to the investigational sequence. All MRI or MRSI procedures, including the standard MRI or MRSI, are no longer than 60 minutes.

Conditions

• Hematopoietic and Lymphoid Cell Neoplasm
• Malignant Solid Neoplasm

Interventions

Type	Name	Description
PROCEDURE	Magnetic Resonance Imaging	Undergo MRI
PROCEDURE	Magnetic Resonance Spectroscopic Imaging	Undergo MRSI

Timeline

• Start date: 2012-04-16
• Primary completion: 2022-09-21
• Completion: 2022-09-21
• First posted: 2019-06-10
• Last updated: 2022-10-28

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study